Meridian Bioscience, Inc.
 

As of: July 3, 2008
Back to 600 Directory

www.meridianbioscience.com

Investor
Relations

Business
Summary

Relative
Standings

Key
Statistics

 
 
 
 

Relative Standings

 — Calendar Year —

 

07/03/08

2007

2006

2005

2004

Price-Close

$27.54

$30.08

$16.35

$13.43

$7.80

Price-High

$37.00

$34.24

$18.67

$15.34

$8.42

Price-Low

$25.20

$16.25

$12.83

$5.90

$4.24

P/E Ratio

37.7

45.6

36.3

38.4

29.3

Relative to:

         
 

S&P MidCap 400 P/E Ratio

237.1%

226.6%

193.5%

163.4%

129.0%

 

S&P 500 P/E Ratio

263.6%

256.5%

224.5%

205.3%

141.5%

 

S&P SmallCap 600 P/E Ratio

223.1%

219.2%

186.4%

174.8%

110.7%

Dividend Yield

2.0%

1.4%

1.9%

1.6%

2.4%

Relative to:

         
 

S&P MidCap 400 Yield

133.7%

120.0%

156.3%

144.4%

217.6%

 

S&P 500 Yield

89.0%

75.8%

104.2%

83.6%

140.8%

 

S&P SmallCap 600 Yield

152.6%

144.0%

208.4%

176.5%

299.1%

A Standard & Poor’s SmallCap 600 Company

Standard & Poor’s a division of The McGraw-Hill Companies

[600 Directory] [Investor Relations] [Business Summary] [Relative Standings] [Key Statistics]